2Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism, J Clin Invest, 1976,57(4) :1079 - 1082.
3Jungers P, Chauveau P, Bandin O, et al. Hyperhomo-cysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab, 1997,23(3 6) :170-173.
4Robinson K, Gupta A, Dennis V, et al. Hyperhomo-cysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation, 1996,94(11 ) :2743-2748.
5Tice JA, Ross E, Coxson PG, et al. Costeffectiveness of vitam in the rapy to jower plasm a homocysteine levels for the prevention of coronary heart disease:Effect of grain fortification and beyond[J]. JAMA, 2001,286(8) :936.
6Madonna P, de Stefano V, Coppola, A, et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke[J]. Stroke, 2002,33(1):51.
7Okatani Y, Wakatsuki A, Reiter RJ. Melatonin counteracts potentiation by homocysteine of KCL-induced vasoconstriction in human umbilical artery: relation to calcium influr [ J ]. Biochem Biophys Res Commun,2001,280(3):940.
8Hackam DG, Peterson JG, Spence JD. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micrommol/L[J]. Am J Hypertens, 2000,13( 1 pt 1 ) : 105.
9Wald DS, Bishop L, Wajd NJ, et al. Random ized triaj of fojic acid sapplementation and serum homocysteine levels [J]. Arch In tern Med,2001,161 (5) :695.
10Refsum H,Ueland P,Nygard O,et al.Homocysteine and cardiovascular disease[J].Annu Rev Med,1998,49:31.
